Cart
sales@molnova.com
(E)-Akt inhibitor-IV
CAS No. 959841-49-7
(E)-Akt inhibitor-IV ( (E)-Akt inhibitor-IV?; CS-1992; (E)-AKTIV )
Catalog No. M28654 CAS No. 959841-49-7
(E)-Akt inhibitor-IV? ((E)-AKTIV) is an inhibitor of PI3K-Akt.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 73 | Get Quote |
|
| 5MG | 122 | Get Quote |
|
| 10MG | 205 | Get Quote |
|
| 25MG | 374 | Get Quote |
|
| 50MG | 510 | Get Quote |
|
| 100MG | 736 | Get Quote |
|
| 200MG | 1017 | Get Quote |
|
| 500MG | 1512 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(E)-Akt inhibitor-IV
-
NoteResearch use only, not for human use.
-
Brief Description(E)-Akt inhibitor-IV? ((E)-AKTIV) is an inhibitor of PI3K-Akt.
-
Description(E)-Akt inhibitor-IV? ((E)-AKTIV) is an inhibitor of PI3K-Akt.(In Vitro):(E)-Akt inhibitor-IV shows little effects on the growth of 184B5 non-cancer cells at the average GI20?doses.
-
Synonyms(E)-Akt inhibitor-IV?; CS-1992; (E)-AKTIV
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetAkt
-
RecptormAChR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number959841-49-7
-
Formula Weight616.6
-
Molecular FormulaC31H29IN4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCN(C1/C=C/N(C)c2ccccc2)c(cc(cc2)-c3nc(cccc4)c4s3)c2N1c1ccccc1.I
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tran JA, et al. Differential coupling of muscarinic M1, M2, and M3 receptors to phosphoinositide hydrolysis in urinary bladder and longitudinal muscle of the ileum of the mouse. J Pharmacol Exp Ther. 2006 Aug;318(2):649-56. Epub 2006 May 4.
molnova catalog
related products
-
A-674563 hydrochlori...
A-674563 is a potent, selective and orally available AKT inhibitor with Ki of 11 nM (Akt1).
-
Honokiol
Honokiol (0, 12.5, 25 and 50 μM) inhibits the growth of GBM cells and induces apoptosis, with IC50 of appr against 30 μM DBTRG-05MG cell.
-
Borussertib
Borussertib is a potent, first-in-class, covalent-allosteric AKT inhibitor.
